An update from Tsumura & Co ( (JP:4540) ) is now available.
Tsumura & Co. has finalized the acquisition period for its treasury shares, a move that was initially announced in February 2025. The acquisition, which involves purchasing up to 1,465,000 common shares on the Tokyo Stock Exchange, is valued at a maximum of 5 billion yen and is set to occur between March 11 and August 29, 2025. This strategic decision is part of the company’s broader financial management strategy, potentially impacting its market positioning and shareholder value.
More about Tsumura & Co
Tsumura & Co. is a company listed on the Tokyo Stock Exchange Prime Market, primarily involved in the production and sale of herbal medicines. The company focuses on leveraging traditional Japanese Kampo medicine to address modern health needs, positioning itself as a leader in the herbal pharmaceutical industry.
YTD Price Performance: -4.67%
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $2.18B
See more data about 4540 stock on TipRanks’ Stock Analysis page.